Pricing Log in Create free account

Capricor Therapeutics, Inc. (CAPR) vs Zura Bio Limited (ZURA)

Capricor Therapeutics, Inc. and Zura Bio Limited are both Biotechnology companies. Capricor Therapeutics, Inc. and Zura Bio Limited are of similar size ($422.7M and $410.2M). Across the 9 metrics below, Zura Bio Limited leads on 6 and Capricor Therapeutics, Inc. on 3.

Valuation

Metric CAPR ZURA Biotechnology median
P/E n/m n/m 8.50
P/S 17.45 n/m 9.71
P/B 1.58 2.50 2.13
Price to free cash flow 2.97 n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 7.41 n/m 9.21
Earnings yield (36.51%) (29.05%) (33.15%)
Free cash flow yield 33.68% (16.75%) (25.50%)

Profitability

Metric CAPR ZURA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (73.70%) (71.76%) (56.36%)
Return on assets (51.53%) (62.74%) (48.04%)
Return on invested capital (1,019.73%) 0.00% 0.00%

Growth

Metric CAPR ZURA Biotechnology median
Revenue growth (TTM) (11.55%) — 6.02%
EPS growth (last fiscal year) (96.52%) (76.67%) 30.26%
Revenue growth, 5-year CAGR 85.83% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CAPR ZURA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.35 12.90 4.72
Net debt to EBITDA 2.99 1.45 0.96

Dividend

Metric CAPR ZURA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CAPR ZURA Biotechnology median
Market cap 422.67m 410.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack